Formula Investing Intl Value 400 A
Name
As ofPrice
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
N/A
1 yr return
21.3%
3 Yr Avg Return
N/A
5 Yr Avg Return
N/A
Net Assets
$14.9 M
Holdings in Top 10
8.7%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 3.12%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 101.00%
Redemption Fee 1.00%
Min Investment
Standard (Taxable)
$5,000
IRA
$5,000
Fund Classification
Fund Type
Open End Mutual Fund
Name
As ofPrice
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
FNVAX - Profile
Distributions
- YTD Total Return N/A
- 3 Yr Annualized Total Return N/A
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 1.94%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameFormula Investing International 400 Fund
-
Fund Family NameFormula Investing, LLC
-
Inception DateDec 17, 2010
-
Shares OutstandingN/A
-
Share ClassNo Load
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerJoel Greenblatt
Fund Description
FNVAX - Performance
Return Ranking - Trailing
Period | FNVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -50.0% | 268.1% | N/A |
1 Yr | 21.3% | -64.8% | 268.1% | N/A |
3 Yr | N/A* | -100.0% | 115.6% | N/A |
5 Yr | N/A* | -100.0% | 58.6% | N/A |
10 Yr | N/A* | -12.1% | 26.2% | N/A |
* Annualized
Return Ranking - Calendar
Period | FNVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -100.0% | 73.0% | N/A |
2022 | N/A | -76.0% | 212.6% | N/A |
2021 | N/A | -65.0% | 900.0% | N/A |
2020 | N/A | -87.3% | 336.8% | N/A |
2019 | N/A | -60.1% | 304.1% | N/A |
Total Return Ranking - Trailing
Period | FNVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -50.0% | 268.1% | N/A |
1 Yr | 21.3% | -64.8% | 268.1% | N/A |
3 Yr | N/A* | -100.0% | 115.6% | N/A |
5 Yr | N/A* | -100.0% | 58.6% | N/A |
10 Yr | N/A* | -12.1% | 26.3% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | FNVAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -100.0% | 76.6% | N/A |
2022 | N/A | -30.7% | 212.6% | N/A |
2021 | N/A | -65.0% | 900.0% | N/A |
2020 | N/A | -87.3% | 341.1% | N/A |
2019 | N/A | -60.1% | 304.1% | N/A |
FNVAX - Holdings
Concentration Analysis
FNVAX | Category Low | Category High | FNVAX % Rank | |
---|---|---|---|---|
Net Assets | 14.9 M | 10 | 804 B | N/A |
Number of Holdings | 452 | 1 | 17333 | N/A |
Net Assets in Top 10 | 1.3 M | -7.11 B | 145 B | N/A |
Weighting of Top 10 | 8.73% | 0.0% | 20474.3% | N/A |
Top 10 Holdings
- iShares MSCI EAFE 4.42%
- Neste Oil Oyj 0.50%
- Television Francaise 1 SA 0.50%
- Seven Group Holdings Ltd. 0.48%
- JB Hi Fi Limited 0.48%
- Telecomunicacoes De Sao Paulo SA-Telesp 0.48%
- OBIC Co., Ltd. 0.48%
- Monadelphous Group Limited 0.46%
- Flextronics International, Ltd. 0.46%
- Taisei Corp 0.46%
Asset Allocation
Weighting | Return Low | Return High | FNVAX % Rank | |
---|---|---|---|---|
Stocks | 97.15% | -142.98% | 259.25% | N/A |
Other | 1.46% | -7288.76% | 493.15% | N/A |
Cash | 1.06% | -2458.20% | 7388.76% | N/A |
Preferred Stocks | 0.33% | -21.20% | 80.89% | N/A |
Convertible Bonds | 0.00% | -0.37% | 144.58% | N/A |
Bonds | 0.00% | -955.59% | 2458.15% | N/A |
Stock Sector Breakdown
Weighting | Return Low | Return High | FNVAX % Rank | |
---|---|---|---|---|
Industrials | 20.97% | -19.53% | 93.31% | N/A |
Consumer Cyclical | 18.80% | -20.80% | 87.44% | N/A |
Technology | 13.92% | -26.81% | 99.57% | N/A |
Basic Materials | 11.09% | -5.18% | 96.19% | N/A |
Consumer Defense | 9.73% | -7.54% | 98.24% | N/A |
Communication Services | 8.14% | -9.27% | 90.02% | N/A |
Healthcare | 7.31% | -15.38% | 100.00% | N/A |
Energy | 5.60% | -6.25% | 144.83% | N/A |
Financial Services | 0.94% | -7.59% | 99.69% | N/A |
Utilities | 0.48% | -3.80% | 94.95% | N/A |
Real Estate | 0.15% | -8.52% | 100.26% | N/A |
Stock Geographic Breakdown
Weighting | Return Low | Return High | FNVAX % Rank | |
---|---|---|---|---|
Non US | 96.76% | -38.73% | 159.65% | N/A |
US | 0.39% | -142.98% | 149.27% | N/A |
FNVAX - Expenses
Operational Fees
FNVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 3.12% | -2.86% | 950.64% | N/A |
Management Fee | 0.85% | 0.00% | 2.87% | N/A |
12b-1 Fee | 0.25% | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.00% | 52000.00% | N/A |
Sales Fees
FNVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 0.00% | 25.00% | N/A |
Deferred Load | N/A | 0.25% | 5.50% | N/A |
Trading Fees
FNVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | 1.00% | 0.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
FNVAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 101.00% | 0.00% | 5067.00% | N/A |
FNVAX - Distributions
Dividend Yield Analysis
FNVAX | Category Low | Category High | FNVAX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 84.51% | N/A |
Dividend Distribution Analysis
FNVAX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Monthly | Annually |
Net Income Ratio Analysis
FNVAX | Category Low | Category High | FNVAX % Rank | |
---|---|---|---|---|
Net Income Ratio | 1.94% | -46.00% | 10.88% | N/A |
Capital Gain Distribution Analysis
FNVAX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Dec 12, 2013 | $0.239 | |
Dec 19, 2012 | $0.182 | |
Dec 16, 2011 | $0.028 |
FNVAX - Fund Manager Analysis
Managers
Joel Greenblatt
Start Date
Tenure
Tenure Rank
Dec 17, 2010
2.96
3.0%
Mr. Greenblatt serves as Managing Principal and Co-Chief Investment Officer of Gotham Asset Management, the successor to Gotham Capital, an investment firm he founded in 1985. Since 1996, he has been a professor on the adjunct faculty of Columbia Business School where he teaches "Value and Special Situation Investing." Mr. Greenblatt serves on the Investment Board for the University of Pennsylvania, and is a director of Pzena Investment Management, Inc., a global investment management firm. Mr. Greenblatt is the author of You Can Be A Stock Market Genius (Simon & Schuster, 1997), The Little Book that Beats the Market (Wiley, 2005), The Little Book that Still Beats the Market (Wiley, 2010), and The Big Secret for the Small Investor (Random House, 2011). He was the Chairman of the Board (1994-1995) and a board member (1994-2000) of Alliant Techsystems, a NYSE-listed aerospace and defense contractor. He holds a BS (1979), summa cum laude, and an MBA (1980) from the Wharton School of the University of Pennsylvania.
Robert Goldstein
Start Date
Tenure
Tenure Rank
Dec 17, 2010
2.96
3.0%
Mr. Goldstein serves as Managing Principal and Co-Chief Investment Officer of Gotham Asset Management, the successor to Gotham Capital, which he joined in 1989. Mr. Goldstein also founded and served as Managing Partner (1989-1997) of Metropolis Partners, a value and special situation investment partnership managing capital on behalf of institutions and wealthy individuals. Mr. Goldstein briefly served on the Executive Committee of the Board of Directors of Old Guard Group, Inc., a publicly-traded insurance company, prior to its being acquired by the Westfield Companies in 2000. He holds a BA (1988), magna cum laude, from Tufts University.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.01 | 33.52 | 5.37 | 3.25 |